scholarly article | Q13442814 |
P50 | author | Songmao Zheng | Q59162284 |
P2093 | author name string | Kenneth E Thummel | |
Yvonne S Lin | |||
Mary F Hebert | |||
Connie L Davis | |||
Xi Emily Zheng | |||
Zhican Wang | |||
Tom Kalhorn | |||
Tauri Senn | |||
P2860 | cites work | Vitamin D deficiency | Q27860616 |
Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1 | Q28208112 | ||
Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent | Q33423450 | ||
Application of 4-(4-nitrophenyl)-1,2,4-triazoline-3,5-dione to analysis of 25-hydroxyvitamin D3 in human plasma by liquid chromatography/electron capture atmospheric pressure chemical ionization-mass spectrometry | Q33427102 | ||
Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography?mass spectrometry | Q33430518 | ||
Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry | Q33445091 | ||
Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay | Q33445994 | ||
A rapid simplified method for plasma 25-hydroxyvitamin D estimation | Q33847882 | ||
Vitamin effects on the immune system: vitamins A and D take centre stage | Q34005584 | ||
Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. | Q34127403 | ||
Enzymes involved in the activation and inactivation of vitamin D. | Q34367819 | ||
Gas chromatography and high-performance liquid chromatography of natural steroids | Q34474543 | ||
Vitamin D in health and disease: current perspectives | Q34481617 | ||
The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going | Q35844249 | ||
Eight cytochrome P450s catalyze vitamin D metabolism | Q35880728 | ||
Vitamin D and sunlight: strategies for cancer prevention and other health benefits | Q36063290 | ||
Measurement of vitamin D status: background, clinical use, and methodologies | Q36586639 | ||
Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry | Q36653540 | ||
Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. | Q36759704 | ||
Vitamin D status: measurement, interpretation, and clinical application | Q37105927 | ||
Vitamin D across the lifecycle: physiology and biomarkers | Q37238601 | ||
Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review | Q37644768 | ||
Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations | Q37699462 | ||
Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry | Q37703677 | ||
Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues | Q37759685 | ||
UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey | Q37780302 | ||
Vitamin D, disease and therapeutic opportunities | Q37814083 | ||
The vitamin D story: a collaborative effort of basic science and clinical medicine. | Q39633660 | ||
Vitamin D: Metabolism and Biological Actions | Q40077237 | ||
Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography | Q40128454 | ||
Current understanding of the molecular actions of vitamin D. | Q40838113 | ||
A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. | Q42960410 | ||
Rapid determination of 25-hydroxy vitamin D3 in swine tissue using an isotope dilution HPLC-MS assay | Q43124721 | ||
Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization | Q43197250 | ||
Competitive protein-binding radioassay for 25-hydroxycholecalciferol | Q43791446 | ||
Sensitive analysis of 1alpha,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry | Q43837238 | ||
Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases | Q44592537 | ||
A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. | Q46038770 | ||
Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference | Q46714969 | ||
Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. | Q53791619 | ||
Ring hydroxylation of 25-hydroxycholecalciferol by rat renal microsomes | Q68419194 | ||
Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer | Q70598693 | ||
The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays | Q79465393 | ||
Isolation and identification of 2alpha,25-dihydroxyvitamin D3, a new metabolite from Pseudonocardia autotrophica 100U-19 cells incubated with Vitamin D3 | Q79753197 | ||
Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction | Q83846483 | ||
P4510 | describes a project that uses | liquid chromatography-tandem mass spectrometry | Q117788892 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin D | Q175621 |
liquid chromatography-tandem mass spectrometry | Q117788892 | ||
P304 | page(s) | 126-133 | |
P577 | publication date | 2011-07-13 | |
P1433 | published in | Analytical Biochemistry | Q485215 |
P1476 | title | Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry | |
P478 | volume | 418 |
Q53087790 | A novel Cookson-type reagent for enhancing sensitivity and specificity in assessment of infant vitamin D status using liquid chromatography/tandem mass spectrometry. |
Q30511948 | An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway |
Q38169562 | Analysis of vitamin D metabolic markers by mass spectrometry: current techniques, limitations of the "gold standard" method, and anticipated future directions |
Q51092138 | CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations. |
Q87828161 | CYP3A4 mutation causes vitamin D-dependent rickets type 3 |
Q37065755 | Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry |
Q36569719 | Chemotyping the distribution of vitamin D metabolites in human serum |
Q99549339 | Clinical Significance of Analysis of Vitamin D Status in Various Diseases |
Q33837169 | Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD |
Q38610163 | Derivatization methods for LC-MS analysis of endogenous compounds |
Q46420176 | Design-of-experiment approach for HPLC analysis of 25-hydroxyvitamin D: a comparative assay with ELISA. |
Q41728004 | Development of a microphysiological model of human kidney proximal tubule function |
Q92748276 | Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial |
Q36721536 | Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia |
Q36498052 | Genetics, Diet, and Season Are Associated with Serum 25-Hydroxycholecalciferol Concentration in a Yup'ik Study Population from Southwestern Alaska |
Q36024406 | Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D₃ function in human colon adenocarcinoma LS180 cells |
Q33610642 | Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability |
Q36545257 | Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 |
Q38171546 | LC-MS/MS in endocrinology: what is the profit of the last 5 years? |
Q55003368 | Measurement of circulating 25-hydroxyvitamin D: A historical review. |
Q36420738 | Method for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometry |
Q89849418 | Quantification of Alfacalcidol Tablets Dissolution Content by Chemical Derivatization and LC-MS |
Q38169758 | Recent trends in the determination of vitamin D. |
Q89587692 | Reevaluating the role of megalin in renal vitamin D homeostasis using a human cell-derived microphysiological system |
Q92825780 | Simple Fast Quantification of Cholecalciferol, 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D in Adipose Tissue Using LC-HRMS/MS |
Q38373794 | Simultaneous quantification of 25-hydroxyvitamin D3-3-sulfate and 25-hydroxyvitamin D3-3-glucuronide in human serum and plasma using liquid chromatography-tandem mass spectrometry coupled with DAPTAD-derivatization |
Q57023146 | Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip |
Q53695740 | The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. |
Q38094123 | Vitamin D and metabolites measurement by tandem mass spectrometry |